{"transactions":[{"id":2080057,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President and COO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:33.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-22-035990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222035990/ownership.xml","form_type":"4"}},{"id":2080056,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President and COO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:33.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":70313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":54687,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":70313},"source":{"system":"sec-edgar","filing":"0001493152-22-035990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222035990/ownership.xml","form_type":"4"}},{"id":2080055,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President and COO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:33.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":171875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":203125,"derivative":{"exercise_price":3.42,"underlying":"Common Stock","underlying_shares":171875},"source":{"system":"sec-edgar","filing":"0001493152-22-035990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222035990/ownership.xml","form_type":"4"}},{"id":2080054,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President and COO"}}],"security":"Common Stock, no par value","published_at":"2022-12-20T16:05:33.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022."}],"balance_after":366500,"source":{"system":"sec-edgar","filing":"0001493152-22-035990","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222035990/ownership.xml","form_type":"4"}},{"id":2181939,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:22:58.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash."}],"balance_after":541500,"source":{"system":"sec-edgar","filing":"0001493152-22-023387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222023387/ownership.xml","form_type":"4"}},{"id":2181938,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:22:58.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date."}],"balance_after":191500,"source":{"system":"sec-edgar","filing":"0001493152-22-023387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222023387/ownership.xml","form_type":"4"}},{"id":2327831,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:27:46.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-22-007206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222007206/ownership.xml","form_type":"4"}},{"id":2327830,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:27:46.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-22-007206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222007206/ownership.xml","form_type":"4"}},{"id":2327829,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, no par value","published_at":"2022-03-17T21:27:46.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":16500,"price":1.198,"value":19767.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $1.198 per share represents a weighted average of prices ranging from $1.180 to $1.200 per share. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price"}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001493152-22-007206","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807104/000149315222007206/ownership.xml","form_type":"4"}},{"id":3171880,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":121435,"kind":"person","name":"Paulsen Gisela","position":1,"cik":"0001807104","reported_name":"Paulsen Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Gen Mgr, Precision Oncology"}}],"security":"Restricted Stock Units","published_at":"2020-04-22T16:18:42.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":66267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on April 20, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on April 20, 2021."}],"balance_after":66267,"derivative":{"underlying":"Common Stock","underlying_shares":66267},"source":{"system":"sec-edgar","filing":"0001209191-20-025344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120025344/doc4.xml","form_type":"4"}}]}